{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:36:12Z","timestamp":1794486972127,"version":"4.9.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Parkinson's UK","award":["G-1004"],"award-info":[{"award-number":["G-1004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The molecular drivers of early sporadic Parkinson\u2019s disease (PD) remain unclear, and the presence of widespread end stage pathology in late disease masks the distinction between primary or causal disease-specific events and late secondary consequences in stressed or dying cells. However, early and mid-stage Parkinson\u2019s brains (Braak stages 3 and 4) exhibit alpha-synuclein inclusions and neuronal loss along a regional gradient of severity, from unaffected-mild-moderate-severe. Here, we exploited this spatial pathological gradient to investigate the molecular drivers of sporadic PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We combined high precision tissue sampling with unbiased large-scale profiling of protein expression across 9 brain regions in Braak stage 3 and 4 PD brains, and controls, and verified these results using targeted proteomic and functional analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We demonstrate that the spatio-temporal pathology gradient in early-mid PD brains is mirrored by a biochemical gradient of a changing proteome. Importantly, we identify two key events that occur early in the disease, prior to the occurrence of alpha-synuclein inclusions and neuronal loss: (i) a metabolic switch in the utilisation of energy substrates and energy production in the brain, and (ii) perturbation of the mitochondrial redox state. These changes may contribute to the regional vulnerability of developing alpha-synuclein pathology. Later in the disease, mitochondrial function is affected more severely, whilst mitochondrial metabolism, fatty acid oxidation, and mitochondrial respiration are affected across all brain regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study provides an in-depth regional profile of the proteome at different stages of PD, and highlights that mitochondrial dysfunction is detectable prior to neuronal loss, and alpha-synuclein fibril deposition, suggesting that mitochondrial dysfunction is one of the key drivers of early disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40478-022-01424-6","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T21:05:33Z","timestamp":1662671133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Mitochondrial dysfunction is a key pathological driver of early stage Parkinson\u2019s"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-3326","authenticated-orcid":false,"given":"Christina E.","family":"Toomey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-8760","authenticated-orcid":false,"given":"Wendy E.","family":"Heywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lachica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Pressey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine C.","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4827-2801","authenticated-orcid":false,"given":"Mesfer","family":"Al Shahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma","family":"D\u2019Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-5603","authenticated-orcid":false,"given":"Iain P.","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9906-0200","authenticated-orcid":false,"given":"Simon","family":"Heales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Orford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-7376","authenticated-orcid":false,"given":"Claire","family":"Troakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-1700","authenticated-orcid":false,"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-0387","authenticated-orcid":false,"given":"Miklos","family":"Palkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-0348","authenticated-orcid":false,"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-4643","authenticated-orcid":false,"given":"Steve M.","family":"Gentleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-0259","authenticated-orcid":false,"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-8288","authenticated-orcid":false,"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-2661","authenticated-orcid":false,"given":"Sonia","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"key":"1424_CR2","doi-asserted-by":"publisher","unstructured":"GBD (2015) Neurological disorders collaborator group (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol, 16:877\u2013897, https:\/\/doi.org\/10.1016\/S1474-4422(17)30299-5","DOI":"10.1016\/S1474-4422(17)30299-5"},{"issue":"Suppl 1","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann H, Stevens CH, Cartwright H, Halliday GM (2014) \u03b1-Synucleinopathy phenotypes. Parkinsonism Relat Disord 20(Suppl 1):S62\u2013S67. https:\/\/doi.org\/10.1016\/S1353-8020(13)70017-8","journal-title":"Parkinsonism Relat Disord"},{"key":"1424_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C et al (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22:1099\u20131109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","journal-title":"Nat Neurosci"},{"key":"1424_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A, Rusconi R, P\u00e9rez-Revuelta BI et al (2013) Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections. EMBO Mol Med 5:1119\u20131127. https:\/\/doi.org\/10.1002\/emmm.201302475","journal-title":"EMBO Mol Med"},{"key":"1424_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","volume":"106","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Alpha-synuclein pathology in Parkinson\u2019s and Alzheimer\u2019s disease brain: incidence and topographic distribution\u2013a pilot study. Acta Neuropathol 106:191\u2013201. https:\/\/doi.org\/10.1007\/s00401-003-0725-y","journal-title":"Acta Neuropathol"},{"key":"1424_CR8","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1074\/jbc.M114.598607","volume":"290","author":"S Sahay","year":"2015","unstructured":"Sahay S, Ghosh D, Dwivedi S et al (2015) Familial parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of \u03b1-synuclein. J Biol Chem 290:7804\u20137822. https:\/\/doi.org\/10.1074\/jbc.M114.598607","journal-title":"J Biol Chem"},{"key":"1424_CR9","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S et al (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem 274:19509\u201319512. https:\/\/doi.org\/10.1074\/jbc.274.28.19509","journal-title":"J Biol Chem"},{"key":"1424_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318\u20131320. https:\/\/doi.org\/10.1038\/3311","journal-title":"Nat Med"},{"key":"1424_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1471-4159.2008.05612.x","volume":"107","author":"C Kim","year":"2008","unstructured":"Kim C, Lee S-J (2008) Controlling the mass action of alpha-synuclein in Parkinson\u2019s disease. J Neurochem 107:303\u2013316. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05612.x","journal-title":"J Neurochem"},{"key":"1424_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28:31\u201340. https:\/\/doi.org\/10.1002\/mds.25373","journal-title":"Mov Disord"},{"key":"1424_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li J-Y, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503. https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"key":"1424_CR14","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/pmic.200400848","volume":"4","author":"M Basso","year":"2004","unstructured":"Basso M, Giraudo S, Corpillo D et al (2004) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteomics 4:3943\u20133952. https:\/\/doi.org\/10.1002\/pmic.200400848","journal-title":"Proteomics"},{"key":"1424_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/prca.200800028","volume":"2","author":"E Kitsou","year":"2008","unstructured":"Kitsou E, Pan S, Zhang J et al (2008) Identification of proteins in human substantia nigra. Proteomics Clin Appl 2:776\u2013782. https:\/\/doi.org\/10.1002\/prca.200800028","journal-title":"Proteomics Clin Appl"},{"key":"1424_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pmic.201300342","volume":"14","author":"V Licker","year":"2014","unstructured":"Licker V, Turck N, K\u00f6vari E et al (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson\u2019s disease pathogenesis. Proteomics 14:784\u2013794. https:\/\/doi.org\/10.1002\/pmic.201300342","journal-title":"Proteomics"},{"key":"1424_CR17","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.jprot.2012.02.032","volume":"75","author":"V Licker","year":"2012","unstructured":"Licker V, C\u00f4te M, Lobrinus JA et al (2012) Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson\u2019s disease. J Proteomics 75:4656\u20134667. https:\/\/doi.org\/10.1016\/j.jprot.2012.02.032","journal-title":"J Proteomics"},{"key":"1424_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s12035-016-0328-y","volume":"55","author":"D Dutta","year":"2018","unstructured":"Dutta D, Ali N, Banerjee E et al (2018) Low levels of prohibitin in substantia nigra makes dopaminergic neurons vulnerable in parkinson\u2019s disease. Mol Neurobiol 55:804\u2013821. https:\/\/doi.org\/10.1007\/s12035-016-0328-y","journal-title":"Mol Neurobiol"},{"key":"1424_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","volume":"9","author":"A Dumitriu","year":"2016","unstructured":"Dumitriu A, Golji J, Labadorf AT et al (2016) Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med Genomics 9:5. https:\/\/doi.org\/10.1186\/s12920-016-0164-y","journal-title":"BMC Med Genomics"},{"key":"1424_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.36","volume":"5","author":"L Ping","year":"2018","unstructured":"Ping L, Duong DM, Yin L et al (2018) Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s Disease. Sci Data 5:180036. https:\/\/doi.org\/10.1038\/sdata.2018.36","journal-title":"Sci Data"},{"key":"1424_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","volume":"39","author":"A Dixit","year":"2019","unstructured":"Dixit A, Mehta R, Singh AK (2019) Proteomics in human parkinson\u2019s disease: present scenario and future directions. Cell Mol Neurobiol 39:901\u2013915. https:\/\/doi.org\/10.1007\/s10571-019-00700-9","journal-title":"Cell Mol Neurobiol"},{"key":"1424_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0006-8993(73)90290-4","volume":"59","author":"M Palkovits","year":"1973","unstructured":"Palkovits M (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59:449\u2013450. https:\/\/doi.org\/10.1016\/0006-8993(73)90290-4","journal-title":"Brain Res"},{"key":"1424_CR23","first-page":"1","volume-title":"Microdissection of individual brain nuclei and areas","author":"M Palkovits","year":"1986","unstructured":"Palkovits M (1986) Microdissection of individual brain nuclei and areas. General Neurochemical Techniques. Humana Press, New Jersey, pp 1\u201318"},{"key":"1424_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/bpa.12842","volume":"30","author":"CE Toomey","year":"2020","unstructured":"Toomey CE, Heywood W, Benson BC et al (2020) Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer\u2019s disease. Brain Pathol 30:794\u2013810. https:\/\/doi.org\/10.1111\/bpa.12842","journal-title":"Brain Pathol"},{"key":"1424_CR25","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1021\/pr1003467","volume":"9","author":"K Bennett","year":"2010","unstructured":"Bennett K, Callard R, Heywood W et al (2010) New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 9:4289\u20134294. https:\/\/doi.org\/10.1021\/pr1003467","journal-title":"J Proteome Res"},{"key":"1424_CR26","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1021\/pr900941z","volume":"9","author":"N Bostanci","year":"2010","unstructured":"Bostanci N, Heywood W, Mills K et al (2010) Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC\/MS E (gingival exudatome). J Proteome Res 9:2191\u20132199. https:\/\/doi.org\/10.1021\/pr900941z","journal-title":"J Proteome Res"},{"key":"1424_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.117.001974","volume":"11","author":"CJ Coats","year":"2018","unstructured":"Coats CJ, Heywood WE, Virasami A et al (2018) Proteomic analysis of the myocardium in hypertrophic obstructive cardiomyopathy. Circ Genom Precis Med 11:e001974. https:\/\/doi.org\/10.1161\/CIRCGEN.117.001974","journal-title":"Circ Genom Precis Med"},{"key":"1424_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12575-016-0045-y","volume":"18","author":"E Bliss","year":"2016","unstructured":"Bliss E, Heywood WE, Benatti M et al (2016) An optimised method for the proteomic profiling of full thickness human skin. Biol Proced Online 18:15. https:\/\/doi.org\/10.1186\/s12575-016-0045-y","journal-title":"Biol Proced Online"},{"key":"1424_CR29","doi-asserted-by":"publisher","first-page":"W741","DOI":"10.1093\/nar\/gki475","volume":"33","author":"B Zhang","year":"2005","unstructured":"Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741\u2013W748. https:\/\/doi.org\/10.1093\/nar\/gki475","journal-title":"Nucleic Acids Res"},{"key":"1424_CR30","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Vasaikar S, Shi Z et al (2017) WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucl Acid Res 45:W130\u2013W137. https:\/\/doi.org\/10.1093\/nar\/gkx356","journal-title":"Nucl Acid Res"},{"key":"1424_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"1424_CR32","doi-asserted-by":"publisher","first-page":"D1258","DOI":"10.1093\/nar\/gkv1001","volume":"44","author":"AC Smith","year":"2016","unstructured":"Smith AC, Robinson AJ (2016) MitoMiner v3.1, an update on the mitochondrial proteomics database. Nucl Acid Res 44:D1258\u2013D1261. https:\/\/doi.org\/10.1093\/nar\/gkv1001","journal-title":"Nucl Acid Res"},{"key":"1424_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.772403","volume":"13","author":"PD Thomas","year":"2003","unstructured":"Thomas PD, Campbell MJ, Kejariwal A et al (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13:2129\u20132141. https:\/\/doi.org\/10.1101\/gr.772403","journal-title":"Genome Res"},{"key":"1424_CR34","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/nn.4160","volume":"18","author":"K Sharma","year":"2015","unstructured":"Sharma K, Schmitt S, Bergner CG et al (2015) Cell type- and brain region-resolved mouse brain proteome. Nat Neurosci 18:1819\u20131831. https:\/\/doi.org\/10.1038\/nn.4160","journal-title":"Nat Neurosci"},{"key":"1424_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8464","author":"D Wang","year":"2018","unstructured":"Wang D, Liu S, Warrell J et al (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science. https:\/\/doi.org\/10.1126\/science.aat8464","journal-title":"Science"},{"key":"1424_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.14.480397","author":"B Zhu","year":"2022","unstructured":"Zhu B, Park J-M, Coffey S et al (2022) Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease Brains. BioRxiv. https:\/\/doi.org\/10.1101\/2022.02.14.480397","journal-title":"BioRxiv"},{"key":"1424_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jgg.2021.01.003","volume":"48","author":"J Zhong","year":"2021","unstructured":"Zhong J, Tang G, Zhu J et al (2021) Single-cell brain atlas of Parkinson\u2019s disease mouse model. J Genet Genomics 48:277\u2013288. https:\/\/doi.org\/10.1016\/j.jgg.2021.01.003","journal-title":"J Genet Genomics"},{"key":"1424_CR38","unstructured":"GitHub - shenlab-sinai\/GeneOverlap: R package for testing and visualizing gene list overlaps. https:\/\/github.com\/shenlab-sinai\/GeneOverlap. Accessed 29 Jul 2022"},{"key":"1424_CR39","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","volume":"10","author":"AP Wingo","year":"2019","unstructured":"Wingo AP, Dammer EB, Breen MS et al (2019) Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun 10:1619. https:\/\/doi.org\/10.1038\/s41467-019-09613-z","journal-title":"Nat Commun"},{"key":"1424_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-015-0059-y","volume":"10","author":"WE Heywood","year":"2015","unstructured":"Heywood WE, Galimberti D, Bliss E et al (2015) Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodeg 10:64. https:\/\/doi.org\/10.1186\/s13024-015-0059-y","journal-title":"Mol Neurodeg"},{"key":"1424_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1023\/a:1022881231253","volume":"25","author":"IP Hargreaves","year":"2002","unstructured":"Hargreaves IP, Heales SJR, Briddon A et al (2002) Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis 25:673\u2013679. https:\/\/doi.org\/10.1023\/a:1022881231253","journal-title":"J Inherit Metab Dis"},{"key":"1424_CR42","doi-asserted-by":"publisher","first-page":"D1251","DOI":"10.1093\/nar\/gkv1003","volume":"44","author":"SE Calvo","year":"2016","unstructured":"Calvo SE, Clauser KR, Mootha VK (2016) MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucl Acid Res 44:D1251\u2013D1257. https:\/\/doi.org\/10.1093\/nar\/gkv1003","journal-title":"Nucl Acid Res"},{"key":"1424_CR43","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","volume":"33","author":"P Sch\u00f6nfeld","year":"2013","unstructured":"Sch\u00f6nfeld P, Reiser G (2013) Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab 33:1493\u20131499. https:\/\/doi.org\/10.1038\/jcbfm.2013.128","journal-title":"J Cereb Blood Flow Metab"},{"key":"1424_CR44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D et al (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1:1269. https:\/\/doi.org\/10.1016\/S0140-6736(89)92366-0","journal-title":"Lancet"},{"key":"1424_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker","year":"2008","unstructured":"Parker WD, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 1189:215\u2013218. https:\/\/doi.org\/10.1016\/j.brainres.2007.10.061","journal-title":"Brain Res"},{"key":"1424_CR46","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1021\/pr301146m","volume":"12","author":"PD Piehowski","year":"2013","unstructured":"Piehowski PD, Petyuk VA, Orton DJ et al (2013) Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J Proteome Res 12:2128\u20132137. https:\/\/doi.org\/10.1021\/pr301146m","journal-title":"J Proteome Res"},{"key":"1424_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","volume":"16","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich JM, Garc\u00eda-Ca\u00f1averas JC, Wang J et al (2020) A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat Chem Biol 16:731\u2013739. https:\/\/doi.org\/10.1038\/s41589-020-0533-x","journal-title":"Nat Chem Biol"},{"key":"1424_CR48","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","volume":"35","author":"L Dunn","year":"2014","unstructured":"Dunn L, Allen GF, Mamais A et al (2014) Dysregulation of glucose metabolism is an early event in sporadic Parkinson\u2019s disease. Neurobiol Aging 35:1111\u20131115. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.001","journal-title":"Neurobiol Aging"},{"key":"1424_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-60761-756-3_18","volume":"648","author":"JB Owen","year":"2010","unstructured":"Owen JB, Butterfield DA (2010) Measurement of oxidized\/reduced glutathione ratio. Methods Mol Biol 648:269\u2013277. https:\/\/doi.org\/10.1007\/978-1-60761-756-3_18","journal-title":"Methods Mol Biol"},{"key":"1424_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.cdd.4401420","volume":"11","author":"A Fico","year":"2004","unstructured":"Fico A, Paglialunga F, Cigliano L et al (2004) Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ 11:823\u2013831. https:\/\/doi.org\/10.1038\/sj.cdd.4401420","journal-title":"Cell Death Differ"},{"key":"1424_CR51","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1089\/ARS.2009.2695","volume":"11","author":"M Mar\u00ed","year":"2009","unstructured":"Mar\u00ed M, Morales A, Colell A et al (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11:2685\u20132700. https:\/\/doi.org\/10.1089\/ARS.2009.2695","journal-title":"Antioxid Redox Signal"},{"key":"1424_CR52","doi-asserted-by":"publisher","first-page":"21749","DOI":"10.1074\/jbc.M312267200","volume":"279","author":"RC Cumming","year":"2004","unstructured":"Cumming RC, Andon NL, Haynes PA et al (2004) Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279:21749\u201321758. https:\/\/doi.org\/10.1074\/jbc.M312267200","journal-title":"J Biol Chem"},{"key":"1424_CR53","doi-asserted-by":"publisher","first-page":"C1735","DOI":"10.1152\/ajpcell.1996.270.6.C1735","volume":"270","author":"DR Janero","year":"1996","unstructured":"Janero DR, Hreniuk D (1996) Suppression of TCA cycle activity in the cardiac muscle cell by hydroperoxide-induced oxidant stress. Am J Physiol 270:C1735\u2013C1742. https:\/\/doi.org\/10.1152\/ajpcell.1996.270.6.C1735","journal-title":"Am J Physiol"},{"key":"1424_CR54","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P, Zampese E, Stout KA et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599:650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"key":"1424_CR55","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1038\/onc.2011.167","volume":"30","author":"A Lemarie","year":"2011","unstructured":"Lemarie A, Grimm S (2011) Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene 30:3985\u20134003. https:\/\/doi.org\/10.1038\/onc.2011.167","journal-title":"Oncogene"},{"key":"1424_CR56","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","volume":"86","author":"BA Faucheux","year":"2003","unstructured":"Faucheux BA, Martin M-E, Beaumont C et al (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 86:1142\u20131148. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01923.x","journal-title":"J Neurochem"},{"key":"1424_CR57","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/ana.410440712","volume":"44","author":"P Jenner","year":"1998","unstructured":"Jenner P, Olanow CW (1998) Understanding cell death in Parkinson\u2019s disease. Ann Neurol 44:S72-84. https:\/\/doi.org\/10.1002\/ana.410440712","journal-title":"Ann Neurol"},{"key":"1424_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-5956-6-8","volume":"6","author":"CJ Werner","year":"2008","unstructured":"Werner CJ, Heyny-von Haussen R, Mall G, Wolf S (2008) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteome Sci 6:8. https:\/\/doi.org\/10.1186\/1477-5956-6-8","journal-title":"Proteome Sci"},{"key":"1424_CR59","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/bpa.12137","volume":"24","author":"P Garcia-Esparcia","year":"2014","unstructured":"Garcia-Esparcia P, Llorens F, Carmona M, Ferrer I (2014) Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson\u2019s disease brain is region dependent. Brain Pathol 24:584\u2013598. https:\/\/doi.org\/10.1111\/bpa.12137","journal-title":"Brain Pathol"},{"key":"1424_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bpa.12474","volume":"28","author":"P Garcia-Esparcia","year":"2018","unstructured":"Garcia-Esparcia P, Koneti A, Rodr\u00edguez-Oroz MC et al (2018) Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson\u2019s disease and Parkinson\u2019s disease with dementia. Brain Pathol 28:43\u201357. https:\/\/doi.org\/10.1111\/bpa.12474","journal-title":"Brain Pathol"},{"key":"1424_CR61","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","volume":"118","author":"I Ferrer","year":"2011","unstructured":"Ferrer I, Martinez A, Blanco R et al (2011) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm 118:821\u2013839. https:\/\/doi.org\/10.1007\/s00702-010-0482-8","journal-title":"J Neural Transm"},{"key":"1424_CR62","doi-asserted-by":"publisher","DOI":"10.1515\/9783110434330-009","author":"DL Wong","year":"2017","unstructured":"Wong DL, Merrifield-MacRae ME, Stillman MJ (2017) Lead(ii) binding in metallothioneins. Met Ions Life Sci. https:\/\/doi.org\/10.1515\/9783110434330-009","journal-title":"Met Ions Life Sci"},{"key":"1424_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20051143","volume":"394","author":"SK Baird","year":"2006","unstructured":"Baird SK, Kurz T, Brunk UT (2006) Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem J 394:275\u2013283. https:\/\/doi.org\/10.1042\/BJ20051143","journal-title":"Biochem J"},{"key":"1424_CR64","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1177\/153537020623100919","volume":"231","author":"M Ebadi","year":"2006","unstructured":"Ebadi M, Sharma S (2006) Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp Biol Med 231:1576\u20131583. https:\/\/doi.org\/10.1177\/153537020623100919","journal-title":"Exp Biol Med"},{"key":"1424_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/152308603322110832","volume":"5","author":"SK Sharma","year":"2003","unstructured":"Sharma SK, Ebadi M (2003) Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. Antioxid Redox Signal 5:251\u2013264. https:\/\/doi.org\/10.1089\/152308603322110832","journal-title":"Antioxid Redox Signal"},{"key":"1424_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2021.1990916","author":"NH Mohamad Najib","year":"2021","unstructured":"Mohamad Najib NH, Yahaya MF, Das S, Teoh SL (2021) The effects of metallothionein in paraquat-induced Parkinson disease model of zebrafish. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2021.1990916","journal-title":"Int J Neurosci"},{"key":"1424_CR67","doi-asserted-by":"publisher","first-page":"15349","DOI":"10.1074\/jbc.M708446200","volume":"283","author":"RS Chung","year":"2008","unstructured":"Chung RS, Penkowa M, Dittmann J et al (2008) Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 283:15349\u201315358. https:\/\/doi.org\/10.1074\/jbc.M708446200","journal-title":"J Biol Chem"},{"key":"1424_CR68","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/glia.23465","volume":"66","author":"R Waller","year":"2018","unstructured":"Waller R, Murphy M, Garwood CJ et al (2018) Metallothionein-I\/II expression associates with the astrocyte DNA damage response and not Alzheimer-type pathology in the aging brain. Glia 66:2316\u20132323. https:\/\/doi.org\/10.1002\/glia.23465","journal-title":"Glia"},{"key":"1424_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cbpa.2012.10.003","volume":"16","author":"AA Sauve","year":"2012","unstructured":"Sauve AA, Youn DY (2012) Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation. Curr Opin Chem Biol 16:535\u2013543. https:\/\/doi.org\/10.1016\/j.cbpa.2012.10.003","journal-title":"Curr Opin Chem Biol"},{"key":"1424_CR70","doi-asserted-by":"publisher","first-page":"E632","DOI":"10.1208\/aapsj080472","volume":"8","author":"T Yang","year":"2006","unstructured":"Yang T, Sauve AA (2006) NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 8:E632\u2013E643. https:\/\/doi.org\/10.1208\/aapsj080472","journal-title":"AAPS J"},{"key":"1424_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","volume":"5","author":"BJ North","year":"2004","unstructured":"North BJ, Verdin E (2004) Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol 5:224. https:\/\/doi.org\/10.1186\/gb-2004-5-5-224","journal-title":"Genome Biol"},{"key":"1424_CR72","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1021\/acschemneuro.0c00696","volume":"11","author":"KY Yeong","year":"2020","unstructured":"Yeong KY, Berdigaliyev N, Chang Y (2020) Sirtuins and their implications in neurodegenerative diseases from a drug discovery perspective. ACS Chem Neurosci 11:4073\u20134091. https:\/\/doi.org\/10.1021\/acschemneuro.0c00696","journal-title":"ACS Chem Neurosci"},{"key":"1424_CR73","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1089\/ars.2016.6662","volume":"26","author":"G Liu","year":"2017","unstructured":"Liu G, Park S-H, Imbesi M et al (2017) Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation And Dysregulates Mitophagy. Antioxid Redox Signal 26:849\u2013863. https:\/\/doi.org\/10.1089\/ars.2016.6662","journal-title":"Antioxid Redox Signal"},{"key":"1424_CR74","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.neuron.2021.08.011","volume":"109","author":"KA Chamberlain","year":"2021","unstructured":"Chamberlain KA, Huang N, Xie Y et al (2021) Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2. Neuron 109:3456-3472.e8. https:\/\/doi.org\/10.1016\/j.neuron.2021.08.011","journal-title":"Neuron"},{"key":"1424_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000374","volume":"15","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira RM, Vicente Miranda H, Francelle L et al (2017) The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 15:e2000374. https:\/\/doi.org\/10.1371\/journal.pbio.2000374","journal-title":"PLoS Biol"},{"key":"1424_CR76","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM et al (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 317:516\u2013519. https:\/\/doi.org\/10.1126\/science.1143780","journal-title":"Science"},{"key":"1424_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116919","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Wales P, Quinti L et al (2015) The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson\u2019s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS ONE 10:e0116919. https:\/\/doi.org\/10.1371\/journal.pone.0116919","journal-title":"PLoS ONE"},{"key":"1424_CR78","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.4103\/1673-5374.145361","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Wang M, Yang L et al (2014) Inhibition of sirtuin 2 exerts neuroprotection in aging rats with increased neonatal iron intake. Neural Regen Res 9:1917\u20131922. https:\/\/doi.org\/10.4103\/1673-5374.145361","journal-title":"Neural Regen Res"},{"key":"1424_CR79","first-page":"120","volume":"8","author":"J Zhang","year":"2016","unstructured":"Zhang J, Wang C, Nie H et al (2016) SIRT2 plays a significant role in maintaining the survival and energy metabolism of PIEC endothelial cells. Int J Physiol Pathophysiol Pharmacol 8:120\u2013127","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"1424_CR80","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, Chhabra G, Ndiaye MA et al (2018) The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Sig 28:643\u2013661. https:\/\/doi.org\/10.1089\/ars.2017.7290","journal-title":"Antioxid Redox Sig"},{"key":"1424_CR81","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1523\/JNEUROSCI.4181-06.2007","volume":"27","author":"W Li","year":"2007","unstructured":"Li W, Zhang B, Tang J et al (2007) Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci 27:2606\u20132616. https:\/\/doi.org\/10.1523\/JNEUROSCI.4181-06.2007","journal-title":"J Neurosci"},{"key":"1424_CR82","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal D, Sandor C, Volpato V et al (2020) A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat Commun 11:4183. https:\/\/doi.org\/10.1038\/s41467-020-17876-0","journal-title":"Nat Commun"},{"key":"1424_CR83","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-021-02343-x","volume":"142","author":"R Feleke","year":"2021","unstructured":"Feleke R, Reynolds RH, Smith AM et al (2021) Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases. Acta Neuropathol 142:449\u2013474. https:\/\/doi.org\/10.1007\/s00401-021-02343-x","journal-title":"Acta Neuropathol"},{"key":"1424_CR84","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41588-020-0610-9","volume":"52","author":"J Bryois","year":"2020","unstructured":"Bryois J, Skene NG, Hansen TF et al (2020) Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease. Nat Genet 52:482\u2013493. https:\/\/doi.org\/10.1038\/s41588-020-0610-9","journal-title":"Nat Genet"},{"key":"1424_CR85","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","volume":"72","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of parkinson disease (2009). Neurology 72:S1-136. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a1d44c","journal-title":"Neurology"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01424-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T21:05:48Z","timestamp":1662671148000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01424-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01424-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was given for all cases. Ethical approval was obtained for the use of post-mortem human brain tissue from the Local Research Ethics Committee of the National Hospital for Neurology and Neurosurgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}